Skip to main content
Clinical Trials/NCT06691971
NCT06691971
Recruiting
Not Applicable

A Pilot Study to Assess Aevice Medical Device for Detection of Wheeze in Pediatric and Adult Populations

Aevice Health Pte. Ltd.1 site in 1 country160 target enrollmentJune 29, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Subject Presenting Wheeze
Sponsor
Aevice Health Pte. Ltd.
Enrollment
160
Locations
1
Primary Endpoint
Wheeze is detected by physician and AeviceMD
Status
Recruiting
Last Updated
7 months ago

Overview

Brief Summary

Respiratory signs and symptoms consisting of wheeze, cough, and breathlessness are obtained in a manual fashion through history taking and physical examination by the healthcare professional. Auscultation of the lung assesses airflow through the trachea-bronchial tree and is helpful in diagnosing various respiratory disorders. AeviceMD is a wearable device that can acquire and process lung sounds, thus assisting in the detection of abnormal lung sounds. The primary objective of this study is to determine if AeviceMD can detect wheeze of pediatrics and adults as accurately as a physician through auscultation. The secondary objective is to investigate if AeviceMD can be used for remote auscultation of breath sounds.

Registry
clinicaltrials.gov
Start Date
June 29, 2023
End Date
December 1, 2026
Last Updated
7 months ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Aevice Health Pte. Ltd.
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • The subject is willing and/or parents/guardians are able to give informed consent for participation in the study.
  • Male or Female, aged ≥ 3 years.
  • Diagnosed with acute asthma exacerbation by an ED provider.

Exclusion Criteria

  • Any other significant disease or disorder which, in the opinion of the Investigator, may either put the subjects at risk because of participation in the study, or may influence the result of the study, or the subject's ability to participate in the study.

Outcomes

Primary Outcomes

Wheeze is detected by physician and AeviceMD

Time Frame: 60 Seconds

Primary endpoint of wheeze will be captured in a binary fashion (i.e. PRESENT or NOT PRESENT) on the CRF by the physician during manual auscultation. AeviceMD will perform wheeze analysis on each 5 sec of recording.

Secondary Outcomes

  • Respiratory sounds are detected and identified by onsite physician and offsite (remote) physician(150 Seconds)

Study Sites (1)

Loading locations...

Similar Trials